# Safety and Effectiveness of Agent Paclitaxel-Coated PTCA Balloon Catheter. (AGENT Japan SV)

> **NCT04058990** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Boston Scientific Corporation** · enrollment: 180 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** Device: Paclitaxel-Coated PTCA Balloon Catheter
- **DEVICE:** SeQuent Please Drug Eluting Balloon Catheter with Paclitaxel

## Key facts

- **NCT ID:** NCT04058990
- **Lead sponsor:** Boston Scientific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-12-12
- **Primary completion:** 2021-12-22
- **Final completion:** 2026-06-30
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2026-05-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04058990

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04058990, "Safety and Effectiveness of Agent Paclitaxel-Coated PTCA Balloon Catheter. (AGENT Japan SV)". Retrieved via AI Analytics 2026-09-21 from https://api.ai-analytics.org/clinical/NCT04058990. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*